These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12663596)

  • 41. Glycemic control and pregnancy outcomes in women with type 1 diabetes mellitus using lispro versus regular insulin: a systematic review and meta-analysis.
    González Blanco C; Chico Ballesteros A; Gich Saladich I; Corcoy Pla R
    Diabetes Technol Ther; 2011 Sep; 13(9):907-11. PubMed ID: 21714679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetic pregnancy outcomes in mothers treated with basal insulin lispro protamine suspension or NPH insulin: a multicenter retrospective Italian study.
    Dalfrà MG; Soldato A; Moghetti P; Lombardi S; Vinci C; De Cata AP; Romanelli T; Bonomo M; Sciacca L; Tata F; Ragazzi E; Filippi A; Burlina S; Lapolla A
    J Matern Fetal Neonatal Med; 2016; 29(7):1061-5. PubMed ID: 25817082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is the use of insulin lispro safe in pregnancy?
    Buchbinder A; Miodovnik M; Khoury J; Sibai BM
    J Matern Fetal Neonatal Med; 2002 Apr; 11(4):232-7. PubMed ID: 12375676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Two consecutive pregnancies in a type 1 diabetic under treatment with insulin Lispro].
    Ahlbach S; Usadel KH; Badenhoop K
    Med Klin (Munich); 2003 Apr; 98(5):245-7. PubMed ID: 12721667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.
    Skrha J; Smahelová A; Andĕl M; Vrtovec M; Subić J; Kreze A; Vozar J; Korecová M; de Verga V; Wyatt J; Metcalfe S; Ristić S
    Sb Lek; 2002; 103(1):15-21. PubMed ID: 12448933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
    Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
    An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.
    Hermansen K; Colombo M; Storgaard H; ØStergaard A; Kølendorf K; Madsbad S
    Diabetes Care; 2002 May; 25(5):883-8. PubMed ID: 11978685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetic retinopathy during pregnancy.
    Axer-Siegel R; Hod M; Fink-Cohen S; Kramer M; Weinberger D; Schindel B; Yassur Y
    Ophthalmology; 1996 Nov; 103(11):1815-9. PubMed ID: 8942876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Practical guidelines on the use of insulin lispro in elderly diabetic patients.
    Benbarka MM; Prescott PT; Aoki TT
    Drugs Aging; 1998 Feb; 12(2):103-13. PubMed ID: 9509289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
    Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M
    Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pregnancy on progression of diabetic retinopathy.
    Klein BE; Moss SE; Klein R
    Diabetes Care; 1990 Jan; 13(1):34-40. PubMed ID: 2404715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A patient with subcutaneous-insulin resistance treated by insulin lispro plus heparin.
    Tokuyama Y; Nozaki O; Kanatsuka A
    Diabetes Res Clin Pract; 2001 Dec; 54(3):209-12. PubMed ID: 11689276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Can insulin humalog be given during pregnancy?].
    Scherbaum WA
    Dtsch Med Wochenschr; 2003 May; 128(21):1190. PubMed ID: 12761695
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.
    Arch Ophthalmol; 1995 Jan; 113(1):36-51. PubMed ID: 7826293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin requirements in type 1 diabetic pregnancy: do twin pregnant women require twice as much insulin as singleton pregnant women?
    Callesen NF; Ringholm L; Stage E; Damm P; Mathiesen ER
    Diabetes Care; 2012 Jun; 35(6):1246-8. PubMed ID: 22432115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Declining insulin requirement in the late first trimester of diabetic pregnancy.
    Jovanovic L; Knopp RH; Brown Z; Conley MR; Park E; Mills JL; Metzger BE; Aarons JH; Holmes LB; Simpson JL;
    Diabetes Care; 2001 Jul; 24(7):1130-6. PubMed ID: 11423491
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Insulin analogs: structure, properties and therapeutic indications. Part 1: rapid-acting insulin analogs].
    Rosak C
    Internist (Berl); 2001 Nov; 42(11):1523-35. PubMed ID: 11732106
    [No Abstract]   [Full Text] [Related]  

  • 60. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    Ophthalmology; 1995 Apr; 102(4):647-61. PubMed ID: 7724182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.